CRYM Stock: Cryomass Technologies Inc. Stock Price, Analysis & Insights
Get live CRYM stock price $0.00, comprehensive Cryomass Technologies Inc. stock analysis, charts, news, and expert forecast. Real-time CRYM stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Cryomass Technologies Inc., established in 2011 and based in Denver, Colorado, specializes in the development, distribution, and commercialization of cryo-mechanical systems. These systems are specifically engineered for processing freshly harvested ...
Company Information
- CEO
- Christian Noel
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 6
Contact Information
- Website
- https://cryomass.com
- Address
- 1001 Bannock Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Lower volatility stock (Beta: -0.22) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Cryomass Technologies Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Cryomass Technologies Inc.
- ⚠Investors should consider how Cryomass Technologies Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
47.43K
P/E Ratio (TTM)
-0.01
Beta
-0.22
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CRYM with peer companies:
- Price
- $0.01
- Market cap
- 863.26K
- Price
- $0.00
- Market cap
- 2.20M
- Price
- $0.02
- Market cap
- 665.16K
- Price
- $0.00
- Market cap
- 156.20K
- Price
- $0.00
- Market cap
- 1.16M
- Price
- $0.00
- Market cap
- 2.21M
- Price
- $0.02
- Market cap
- 2.11M
- Price
- $0.00
- Market cap
- 5.40K
- Price
- $0.00
- Market cap
- 62.89K
- Price
- $0.00
- Market cap
- 34.75K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.